95 results
Therapeutic Indications for the Anticonvulsant Agents

#Anticonvulsant #Antiseizure #Medications #Pharmacology #Table #Neurology #Epilepsy #Management
Therapeutic Indications ... Anticonvulsant Agents ... #Antiseizure #Medications ... #Pharmacology #Table ... #Neurology #Epilepsy
REBEL Review 4 & 5: Paralytic & Vasopressor Dosing 

Paralytic Agents:
 - Succinylcholine (Depolarizing Agent)
Paralytic Agents ... (Depolarizing Agent ... resuscitation #table ... pharmacology #dosing #medications ... #Comparison
Summary of Non-Insulin Agents Used to Treat Diabetes

#Diabetes #Pharmacology #Comparison #Table #Medications #Noninsulin #Orals #Agents
of Non-Insulin Agents ... #Pharmacology #Comparison ... #Table #Medications ... Noninsulin #Orals #Agents
FDA-Approved 1st line Medications for Tobacco Cessation Treatment

Nicotine patch, Nicotine lozenge, Nicotine gum, Nicotine inhaler, Nicotine
FDA-Approved 1st line Medications ... , Varenicline (tablet ... release (SR) (tablet ... Cessation #Therapy #Comparison ... #Table #Agents
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
Comparison of anti-diabetic ... Each class of medications ... pharmacotherapy #table ... #comparison #management ... #medications #diabetes
Nonopioid Analgesic Agents
Acetaminophen
Aspirin
NSAIDs
Amitriptyline
Duloxetine
Gabapentin
Pregabalin
Lidocaine Patch
Capsaicin Patch

#Nonopioid #Analgesic #medications #drugs #comparison #table #pharmacology
Nonopioid Analgesic Agents ... Nonopioid #Analgesic #medications ... #drugs #comparison ... #table #pharmacology
Key Characteristics of Old and New Potassium-Binding Agents

- Dr. Edgar V. Lerma https://twitter.com/edgarvlermamd

#Potassium #Binding #KBinders #Kayexelate
Potassium-Binding Agents ... KBinders #Kayexelate #Comparison ... #Table #Pharmacology ... #HyperKalemia #Nephrology ... #Agents
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications ... Summary Table ... major adverse CV events ... #diabetes #medications ... #table #comparison
Catecholamine Vasopressor Effect Sites and Indications #Pathophys #Management #EM #IM #PCC #Catecholamine #Comparison #Table #Epi #Norepi
Effect Sites and Indications ... Management #EM #IM #PCC ... Catecholamine #Comparison ... #Table #Epi #Norepi
Therapy for AL Amyloidosis 2019 
 - Antibodies (Plasma cells) 
 - Proteasome Inhibitors 
 -
Therapy for AL Amyloidosis ... - Alkylating Agents ... Steroids - Novel Agents ... ALAmyloidosis #Therapy #Medications ... Pharmacology #Management #Classes